NCT06245915
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06245915
Title AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Arsenal Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Hospital Phoenix Arizona 85054 United States Details
City of Hope Duarte California 91010 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
University of Iowa and Holden Comprehensive Cancer Center Iowa City Iowa 52242 United States Details
Dana Farber Cancer Institue Boston Massachusetts 02215 United States Details
Perlmutter Cancer Center - NYU Langone Health New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
MD Anderson Cancer Center Houston Texas 77030 United States Details
Huntsman Cancer Institute - Univ of Utah Health Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field